Structure Therapeutics Inc. American Depositary Shares (GPCR)

Structure Therapeutics Inc. American Depositary Shares (GPCR) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.6B; returns 1 day -3.4%, 1 week +0.5%, 1 year -20.2%.

Structure Therapeutics Inc. (GPCR) is a clinical-stage global biopharmaceutical company dedicated to the discovery and development of novel oral small molecule therapeutics. The company primarily leverages a proprietary structure-based drug discovery platform, integrating advanced structural biology, computational chemistry, and medicinal chemistry, to target G protein-coupled receptors (GPCRs).

Groups GPCR belongs to

• GLP-1 Agonists
• GPCR Targeting
• Metabolic Disorders
• Biotechnology
• Clinical Stage Biotech
• Drug Discovery
• Weight Management
• Healthcare
• Clinical Stage
• Pharmaceuticals
• Biopharmaceutical
• Life Sciences
• Clinical Stage Biopharma
• Healthcare Technology

GPCR financial model: income statement, cash flow and balance sheet